Authors: Muralikrishnan, D Ebadi, M

Citation: D. Muralikrishnan et M. Ebadi, SKF-38393, a dopamine receptor agonist, attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity, BRAIN RES, 892(2), 2001, pp. 241-247

Authors: Sarkar, S Thomas, B Muralikrishnan, D Mohanakumar, KP

Citation: S. Sarkar et al., Effects of serotoninergic drugs on tremor induced by physostigmine in rats, BEH BRA RES, 109(2), 2000, pp. 187-193

Authors: Usha, R Muralikrishnan, D Thomas, B Ghosh, S Mandal, C Mohanakumar, KP

Citation: R. Usha et al., Region-specific attenuation of a trypsin-like protease in substantia nigrafollowing dopaminergic neurotoxicity by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, BRAIN RES, 882(1-2), 2000, pp. 191-195

Authors: Mohanakumar, KP Muralikrishnan, D Thomas, B

Citation: Kp. Mohanakumar et al., Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity, BRAIN RES, 864(2), 2000, pp. 281-290

Authors: Thomas, B Muralikrishnan, D Mohanakumar, KP

Citation: B. Thomas et al., In vivo hydroxyl radical generation in the striatum following systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice, BRAIN RES, 852(1), 2000, pp. 221-224

Authors: Mohanakumar, KP Muralikrishnan, D

Citation: Kp. Mohanakumar et D. Muralikrishnan, Neurochemical mechanisms underlying neuroprotective actions of bromocriptine, salicylate, D- and L-deprenyl in neurodegeneration caused by MPTP, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 289-293